A detailed history of Alphabet Inc. transactions in Invitae Corp stock. As of the latest transaction made, Alphabet Inc. holds 235,606 shares of NVTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
235,606
Previous 235,606 -0.0%
Holding current value
$0
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$1.2 - $2.73 $23,569 - $53,619
19,641 Added 9.09%
235,606 $318,000
Q3 2021

Nov 14, 2022

BUY
$24.31 - $33.6 $5.25 Million - $7.26 Million
215,965 New
215,965 $6.14 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Alphabet Inc. Portfolio

Follow Alphabet Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphabet Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alphabet Inc. with notifications on news.